1 / 20

Guilin Pharmaceutical Co. Supports WHO ACTs Project for Affordable Antimalarial Treatments

Guilin Pharmaceutical Co., Ltd. is committed to enhancing access to antimalarial treatments by establishing a complete Artesunate industrial chain, including extraction, cultivation, and production of Artesunate tablets and injections. With large-scale plantations in Guangxi and Hunan provinces, covering up to 75 million m², the company ensures high-quality production that meets WHO GMP standards. The focus on reducing manufacturing costs allows Guilin Pharma to supply affordable ACTs like ARSUAMOON and ARTECOSPE. Ongoing R&D aims to develop new antimalarial solutions, particularly for children.

keran
Télécharger la présentation

Guilin Pharmaceutical Co. Supports WHO ACTs Project for Affordable Antimalarial Treatments

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Support to WHO ACTs Project Guilin Pharmaceutical Co,.Ltd. 22 Mar 2006

  2. 1. Advantage on ACTs resource 1.1 Guilin Pharma has established its own Artesunate industrial chain

  3. Artesunate Industrial Chain Extraction ARTESUNATE Seeds selection Cultivation Amodiaquine Amodiaquine Tablets ARSUAMOON (AS+AQ) ARTESUNATE Tablets ARTESUNATE for Injection

  4. Seeds Selection

  5. Cultivation

  6. Extraction

  7. Artesunate for Injection

  8. Artesunate tablets production line

  9. ARSUAMOON (AS+AQ) production line

  10. 1.2 In Feb of 2006, Guilin Pharma built up the large-scale plantation base in Guangxi, Hunan and Sichuan province of China, which covers an area of 70 million ~ 75 million M2.

  11. 1.3 Production capacity Million

  12. 2 Established Quality Assurance System 2.1The products are manufactured and conform to WHO GMP requirement

  13. 2.2 The products specifications conform to the WHO required standards IP USP BP

  14. 2.3 ARTESUNATE Tablets has been listed in WHO pre-qualification Programme

  15. 3. To reduce cost to make ACTs affordable Improve the manufactory capacity to supply ACTs, to make every effort to reduce the cost a. Manufactory Cost b. Management Cost To supply ACTs at reasonable price

  16. 4. Guilin Pharma ACTs 4.1 ARSUAMOON Artesunate Tablets + Amodiaquine Hydrochloride Tablets

  17. 4.2 ARTECOSPE Artesunate Tablets + Sulfadoxine/Pyrimethamine Tablets

  18. 4.3 Artesunate for Injection

  19. 5. Research & Development on New Antimalarial 5.1 Antimalarial for infant and children 5.2 Artesunate fixed-dosage 5.3 Artesunate for Injection (new and more convenient use)

  20. Thank you! Welcome to Guilin

More Related